Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer

Neurooncol Adv. 2021 Nov 30;3(1):vdab178. doi: 10.1093/noajnl/vdab178. eCollection 2021 Jan-Dec.
No abstract available

Keywords: PET/CT; brain metastases; breast cancer; estrogen receptor.